KYNTRA BIO, INC. (KYNB) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2012: -$46.25M2013: -$60.83M2014: $240.68M2015: $153.17M2016: $135.07M2017: $547.74M2018: $528.47M2019: $535.41M2020: $441.45M2021: $229.11M2022: -$1.48M2023: -$183.68M2024: -$205.12M2025: -$17.00M-$17.00M
2012Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$17.00M+91.7%
2024-$205.12M-11.7%
2023-$183.68M-12310.7%
2022-$1.48M-100.6%
2021$229.11M-48.1%
2020$441.45M-17.5%
2019$535.41M+1.3%
2018$528.47M-3.5%
2017$547.74M+305.5%
2016$135.07M-11.8%
2015$153.17M-36.4%
2014$240.68M+495.6%
2013-$60.83M-31.5%
2012-$46.25M